Presentation is loading. Please wait.

Presentation is loading. Please wait.

Age-standardized mortality from ischaemic heart disease in European regions (men; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart.

Published byMaryann Stanley Modified over 8 years ago

Similar presentations

Presentation on theme: "Age-standardized mortality from ischaemic heart disease in European regions (men; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart."— Presentation transcript:

1 Age-standardized mortality from ischaemic heart disease in European regions (men; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

2 Age-standardized mortality from ischaemic heart disease in European regions (women; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

3 Age-standardized mortality from cerebrovascular disease in European regions (men; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

4 Age-standardized mortality from cerebrovascular disease in European regions (women; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

5 Age-standardized mortality from cardiovascular disease, i.e. ischaemic heart disease and cerebrovascular disease combined, in European regions (men; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

6 Age-standardized mortality from cardiovascular disease, i.e. ischaemic heart disease and cerebrovascular disease combined, in European regions (women; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

7 Age-standardized mortality rates (45–74 years) from ischaemic heart disease in Europe (2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

8 Age-standardized mortality rates (45–74 years) from cerebrovascular disease in Europe (2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

9 Age-standardized mortality rates (45–74 years) from all-cause mortality in Europe (2000) J Muller-Nordhorn, et al. Eur Heart J 2008;29:Epub online

Download ppt "Age-standardized mortality from ischaemic heart disease in European regions (men; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart."

Similar presentations

Statins for ischaemic heart disease: Excellence and equity Hackney, Newham & Tower Hamlets.

Statins for ischaemic heart disease: Excellence and equity Hackney, Newham & Tower Hamlets.
Mortality by country of birth in England and Wales, 2001-2003 Clare Griffiths & Anita Brock: Office for National Statistics Sarah Wild & Colin Fischbacher:

Mortality by country of birth in England and Wales, Clare Griffiths & Anita Brock: Office for National Statistics Sarah Wild & Colin Fischbacher:
Key messages Stephen S Lim, et al. Lancet 2007; 370: 2054-62.

Key messages Stephen S Lim, et al. Lancet 2007; 370:
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.

PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-

Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-
Cardiovascular mortality in Russia and other countries

Cardiovascular mortality in Russia and other countries
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH by Antigone.

The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH by Antigone.
Canadian Cardiovascular Outcomes Research Team www.ccort.ca A Canadian Institutes of Health Research - Heart and Stroke Foundation of Canada Interdisciplinary.

Canadian Cardiovascular Outcomes Research Team A Canadian Institutes of Health Research - Heart and Stroke Foundation of Canada Interdisciplinary.
Competing causes of death European Society of Cardiology Congress Paris, August 28, 2011 Ulrich Keil and Angela Spelsberg Institute of Epidemiology and.

Competing causes of death European Society of Cardiology Congress Paris, August 28, 2011 Ulrich Keil and Angela Spelsberg Institute of Epidemiology and.
Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]
Zacho J, et al. N Engl J Med 2008;359:1897-908 Risk of Ischemic Heart Disease as a Function of Plasma Levels of C-Reactive Protein (CRP) in the General.

Zacho J, et al. N Engl J Med 2008;359: Risk of Ischemic Heart Disease as a Function of Plasma Levels of C-Reactive Protein (CRP) in the General.
Consider testing if person is: – Overweight or obese with additional risk factor for diabetes – Age 45 or older Obtain: A1C or FPG or 2-hour plasma glucose.

Consider testing if person is: – Overweight or obese with additional risk factor for diabetes – Age 45 or older Obtain: A1C or FPG or 2-hour plasma glucose.
Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes Featured Article: Araz Rawshani, Ann-Marie.

Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes Featured Article: Araz Rawshani, Ann-Marie.
Berlin 26.03.2015 Mare Ainsaar. Population influences everything Values Housing Media use Transportation Services Criminality Innovation Natural recources.

Berlin Mare Ainsaar. Population influences everything Values Housing Media use Transportation Services Criminality Innovation Natural recources.
WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.

WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.
How can you estimate simply the cardiovascular risk of your patients?

How can you estimate simply the cardiovascular risk of your patients?
Central blood pressure: what do we really know today?

Central blood pressure: what do we really know today?
The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality by Jane Østergaard.

The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality by Jane Østergaard.
Primary care organisational interventions for secondary prevention of ischaemic heart disease: a systematic review and meta-analysis by Edel Murphy, Akke.

Primary care organisational interventions for secondary prevention of ischaemic heart disease: a systematic review and meta-analysis by Edel Murphy, Akke.
Parish S, et al. Eur Heart J 2009 [Epub ahead of print]

Parish S, et al. Eur Heart J 2009 [Epub ahead of print]

Similar presentations

Ads by Google